RSVAX | VMVAX | RSVAX / VMVAX | |
Total Expense Ratio | 1.30 | 0.07 | 1,857% |
Annual Report Gross Expense Ratio | 1.33 | 0.07 | 1,900% |
Fund Existence | 32 years | 14 years | - |
Gain YTD | 2.849 | 3.573 | 80% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 264M | 29.9B | 1% |
Annual Yield % from dividends | 0.37 | 2.26 | 17% |
Returns for 1 year | 0.21 | 12.14 | 2% |
Returns for 3 years | 7.78 | 28.52 | 27% |
Returns for 5 years | 35.26 | 77.08 | 46% |
Returns for 10 years | -21.11 | 88.11 | -24% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NWHHX | 15.58 | 0.15 | +0.97% |
Nationwide Bailard Cogntv Val Instl Svc | |||
AMFCX | 58.96 | 0.38 | +0.65% |
American Funds American Mutual C | |||
FSEIX | 56.84 | 0.27 | +0.48% |
Nuveen Mid Cap Value Opportunities I | |||
VSEAX | 41.57 | 0.20 | +0.48% |
JPMorgan Small Cap Equity A | |||
RTXCX | 12.69 | 0.05 | +0.40% |
Russell Inv Tax-Managed Real Assets C |